1. Dose Adjustment Associated Complications of Bone Morphogenetic Protein: A Longitudinal Assessment
- Author
-
Allan D. Levi, Turki Elarjani, Frank De Stefano, Joshua D. Burks, and Stephen Burks
- Subjects
medicine.medical_specialty ,Vertebral level ,Bone Morphogenetic Protein 2 ,Anterior cervical discectomy and fusion ,Bone morphogenetic protein ,Cohort Studies ,Postoperative Complications ,Transforming Growth Factor beta ,Dose adjustment ,Humans ,Medicine ,Longitudinal Studies ,Cervical fusion ,Retrospective Studies ,Dose-Response Relationship, Drug ,business.industry ,Retrospective cohort study ,Recombinant Proteins ,Surgery ,Spinal Fusion ,Spinal Diseases ,Neurology (clinical) ,Neurosurgery ,Complication ,business ,Diskectomy - Abstract
Bone morphogenetic protein (BMP) is a growth factor that aids in osteoinduction and promotes bone fusion. There is a lack of literature regarding recombinant human BMP-2 (rhBMP-2) dosage in different spine surgeries. This study aims to investigate the trends in rhBMP-2 dosage and the associated complications in spinal arthrodesis.A retrospective study was conducted investigating spinal arthrodesis using rhBMP-2. Variables including age, procedure type, rhBMP-2 size, complications, and postoperative imaging were collected. Cases were grouped into the following surgical procedures: anterior lumbar interbody fusion/extreme lateral interbody fusion (ALIF/XLIF), posterior lumbar interbody fusion/transforaminal lumbar interbody fusion (PLIF/TLIF), posterolateral fusion (PLF), anterior cervical discectomy and fusion (ACDF), and posterior cervical fusion (PCF).A total of 1209 patients who received rhBMP-2 from 2006 to 2020 were studied. Of these, 230 were categorized as ALIF/XLIF, 336 as PLIF/TLIF, 243 as PLF, 203 as ACDF, and 197 as PCF. PCF (P0.001), PLIF/TLIF (P0.001), and PLF (P0.001) demonstrated a significant decrease in the rhBMP-2 dose used per level, with major transitions seen in 2018, 2011, and 2013, respectively. In our sample, 129 complications following spinal arthrodesis were noted. A significant relation between rhBMP-2 size and complication rates (χBMP is an effective compound in fusing adjacent spine segments. However, it carries some regional complications. We demonstrate a decreasing trend in the dose/vertebral level. A decrease rhBMP-2 dose per level correlated with a decrease in complication rates.
- Published
- 2021